PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / COM
Total 13F shares
1,186,826
Share change
-22,256
Total reported value
$2,872,367
Price per share
$2.42
Number of holders
25
Value change
-$54,190
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q2 2024

As of 30 Jun 2024, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,186,826 shares. The largest 10 holders included 22NW, LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, RBF Capital, LLC, BlackRock Inc., WEDBUSH SECURITIES INC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, SANTA MONICA PARTNERS LP, and NORTHERN TRUST CORP. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.